Current landscape of clinical development and approval of advanced therapies

Autor: Carolina Iglesias-Lopez, Antonia Agustí, Antoni Vallano, Merce Obach

Publikováno v: Molecular Therapy: Methods & Clinical Development, Vol 23, Iss , Pp 606-618 (2021)

Advanced therapy medicinal products (ATMPs) are innovative therapies that mainly target orphan diseases and high unmet medical needs. The uncertainty about the product's benefit-risk balance at the time of approval, the limitations of nonclinical dev

Externí odkaz: https://doaj.org/article/43c715acca8f4480a4c1e57dcd181861

Comprehensive Analysis of the ILCs and Unconventional T Cells in Virus Infection: Profiling and Dynamics Associated with COVID-19 Disease for a Future Monitoring System and Therapeutic Opportunities

Autor: Elena Lo Presti, Andrea De Gaetano, Giovanni Pioggia, Sebastiano Gangemi

Publikováno v: Cells, Vol 11, Iss 542, p 542 (2022)
Cells 11 (2022): 542. doi:10.3390/cells11030542
info:cnr-pdr/source/autori:Elena Lo Presti; Andrea De Gaetano; Giovanni Pioggia; Sebastiano Gangemi/titolo:Comprehensive Analysis of the ILCs and Unconventional T Cells in Virus Infection: Profiling and Dynamics Associated with COVID-19 Disease for a Future Monitoring System and Therapeutic Opportunities/doi:10.3390%2Fcells11030542/rivista:Cells/anno:2022/pagina_da:542/pagina_a:/intervallo_pagine:542/volume:11

This review is a comprehensive analysis of the effects of SARS-CoV-2 infection on Unconventional T cells and innate lymphoid cells (ILCs). COVID-19 affected patients show dysregulation of their adaptive immune systems, but many questions remain unsol

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff834e324abb897092eac44ed0a4980c
https://www.mdpi.com/2073-4409/11/3/542

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.